Delivery Order SPE2DB22D1106-SPE2DB24FEPY2
Award Date
5/3/24
Potential Completion Date
5/6/24
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,814.40 firm-fixed-price delivery order is for the supply of 4,564,895,994 glipizide ER 10 mg tablets. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,559 units of the pharmaceutical product Glipizide ER 10 mg tablets. The $4,974.55 Firm Fixed Price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4,564,804,911 tablets of Glipizide ER 10 mg, a medication used to treat type 2 diabetes. The $2,641.54 firm fixed price delivery order was issued under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide Glimepiride 4 mg tablet 100s to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $2,849.69 and an Ultimate Completion Date of September 19, 2024. Amerisourcebergen has a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,121,745 Glimepiride 4 MG tablets in packages of 100. The $3,771.57 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) on July 11, 2024, with a completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the...
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $3,273.93 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,478,133 tablets of the medication Glimepiride 4 mg and has a period of performance through May 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999.00 through December 31, 2025,...
This is a firm fixed-price delivery order under contract SPE2DX15D1205 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,509.18 award is for 1,000 tablets of Glipizide ER 10 mg, a medication used to treat diabetes. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract with the DLA, which provides a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a pharmaceutical product, specifically the drug Glimepiride 4 mg tablets, to the Defense Logistics Agency (DLA). The contract, valued at $4,600.92, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle...
This is a delivery order awarded to Amerisourcebergen Drug Corp Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of Glimepiride 4 mg tablets. The contract has a firm fixed price of $2,346.39 and a completion date of August 7, 2024. This award is not associated with a set-aside program. As a major pharmaceutical distributor, Amerisourcebergen has extensive experience providing a wide range of medical products and supplies to the U.S. federal government, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,728.32 Firm Fixed Price Delivery Order covers the supply of 4,566,448,576 tablets of the medication Glimepiride 2 mg. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...